Navigation Links
USP publishes Spanish edition of United States Pharmacopeia and National Formulary
Date:2/4/2008

Rockville, Md., February 4, 2008 The U.S. Pharmacopeia (USP) is pleased to announce that the third annual Spanish edition of its core compendia, the United States Pharmacopeia and National Formulary (USPNF), is now available for purchase. The official edition for 2008, USP 31NF 26, provides specifications needed to produce more than 4,000 quality pharmaceuticals, excipients, dietary supplements, biologics and other therapeutics.

USPNF, recognized by U.S. federal law as the official compendia for drug standards, offers access to monographs defining the required standards for the identity, quality, purity, strength, labeling and packaging for prescription and over-the-counter medications, dietary supplements and other health care products. These standards are enforceable by the U.S. Food and Drug Administration for drugs marketed in or exported to the United States, and are also recognized by governments and regulatory agencies throughout the world.

USP is proud to offer a Spanish edition of the USPNF for the third year in a row, said Darrell Abernethy, M.D., Ph.D., chief science officer of USP. By translating the compendia, we hope to better meet the needs of our Spanish-speaking partners as we work together to advance USPs mission of providing good pharmaceutical care for all people, all over the world.

The Spanish edition, Farmacopea de los Estados Unidos de Amrica-Formulario National, is an official, expert translation of the USPNF in English. Written in a universal, neutral Spanish, the translation process is supervised by USPs Spanish Advisory Panela dedicated body of leading scientific experts from Spanish-speaking countries. USP offers expert scientific and technical support in Spanish during business hours that are convenient for Spanish-speaking customers.

USPNF is used by quality assurance and quality control scientists, pharmaceutical manufacturers, regulatory professionals, compounding professionals, lawyers, and
'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. American College of Physicians publishes The Fenway Guide to LGBT Health
3. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
4. Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis
5. American College of Physicians publishes "Peripheral Arterial Disease"
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
7. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
8. The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research
9. Springer publishes La Chirurgia degli Organi de Movimento
10. The Diabetes Educator publishes systematic reviews for diabetes management
11. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ed, "frozen lozenge" provides breakthrough method ..., Dec. 2 "A spoonful of sugar help... it just isn,t that easy. That,s why Insight Phar...e, frozen single-use packages that offer cooling, ...shest sore throats. , , Sucrets ICE is th...
(Date:12/2/2008)... For most people, family gatherings, ...he fun of the holiday season. Not so for those wit...d--social situations, reports the December 2008 is... Boston (Vocus) December 2, 2008 --...other social activities are part of the fun of the...
(Date:12/2/2008)...Dec. 2 EIN News has ann...g in-depth news on brain cancer. , , With n...e finding out that information is one of the key c...ding to the growing demand for accurate informatio...procedures and drugs to treat it, EIN News is intr...
(Date:12/2/2008)...orice, pancakes, among other products, home to sod...althDay News) -- There can be plenty of sodium -- ... health-friendly, and shoppers should know that lo...fat products. , That,s the finding of a report ...zine. , Researchers analyzed 37 common supermar...
Breaking Medicine News(10 mins):Health News:New Sucrets(R) ICE Cools Sore Throat Pain 2Health News:Easing Social Anxiety During the Holidays: Tips from Harvard Women's Health Watch 2Health News:EIN News Introduces 'Brain Cancer News Today'; Website Offers Information on Risk Factors, Treatment, Drugs 2Health News:High Salt Levels Common in Many Foods 2
... virtual reality simulation tools are making denti... if M. Cenk Cavusoglu has his // way, then this me...rform delicate surgeries in a risk-free manner. "...cause it reduces the learning time and allows stud...
...n Victoria have claimed that they have developed a...se two viruses in question can easily kill humans ...harge sheet against the viruses is that Hendra vir...minent Queensland racehorse trainer Vic Rail and 1...
...uncture, even sham acupuncture may be as effective...omparable level of treatment efficacy has been doc... results were obtained with respect to reduction i...with a diagnosis of migraine were included for the...
... Organization to investigate the possibility of bu...ks of bird flu//. They are already ready to invest... investigation with bird flu virus is already bein...ns in the House of Commons about the UK's prepared...
Other Medicine News:
(Date:11/28/2008)...ember 28 German biotech company,P...lized HIV monitoring and,AIDS patient follow-up d...In,the year 2008, 2.5 million patient tests have ...ly affordable "CyFlow" system, supporting already,...Due to introduction of the,Partec innovation, the...
(Date:11/26/2008)...ity, automation and intelligent clinical applicati...ll new level , , CHICAGO, Ill., Nov. 26 /PR...w.siemens.com/healthcare ) highlights the ACUSON ...), the world,s first multi-use, automated volume ...ssembly and Annual Meeting of the Radiological Soc...
(Date:11/25/2008)...dents against expanding statin use broadly in wake....J., Nov. 25 JUPITER, a clinical t...ascular risk of healthy patients with elevated CRP...adults, according to a national poll directed at h...part in the online poll conducted by medical news ...
(Date:11/25/2008)...linical Trial to Assess Survival of Patients Recei...resectable Hepatocellular Carcinoma , , BEL...es Oncology, Inc. (LSO) today announced the comple...ial of Light Infusion Therapy(TM) (Litx(TM)) as a ...a (HCC), also known as hepatoma or primary liver c...
Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Citizens Republic Bancorp Selects HealthPlus as Sole Provider of Health Insurance for 2009 30619 1Citizens Republic Bancorp Selects HealthPlus as Sole Provider of Health Insurance for 2009 30619 2Travis E Baugh Named President COO of HEALTHPOINT Ltd 30614 1Travis E Baugh Named President COO of HEALTHPOINT Ltd 30614 2Protein folding researcher David Baker to receive Sackler Prize in Biophysics 6038 1Protein folding researcher David Baker to receive Sackler Prize in Biophysics 6038 2Huntington Area Development Council Attracts Technology Based Startup Companies With 24150 000 Grant From Verizon West Virginia 9358 1Huntington Area Development Council Attracts Technology Based Startup Companies With 24150 000 Grant From Verizon West Virginia 9358 2
...h 12, 2007--Inflazyme,Pharmaceuticals Ltd. (TSX: I...nary results of the Phase 2b CAPSICS study with,IP...nce between,patients who received drug or placebo....rge and consistent across a number of,the end-poin... its,external experts to determine if anything unt...
...r BLA filing for C1-inhibitor,replacement therapy,...- Lev,Pharmaceuticals, Inc. (Lev) today announced ...rial of C1-esterase inhibitor (C1-INH),for the acu...e,acute study, which is part of the company,s CHAN...anofiltration Generation,evaluating Efficacy), the...
Other Medicine Technology:Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 2Inflazyme Announces Outcome of Review of Phase 2b Asthma Study:,Potential Mitigating Factors Identified which Prevent Clear,Interpretation of Results 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
...feature-packed projectors ideal for any practice. ...for longer life -- up to 2,000 hours under typical...tial cost with an incandescent illumination system.... And both provide exceptionally even illumination...
...cal design and utilizes a multi-layered, multi-coa... producing a measurable 20% increase in optical re...lity of the Ultra Series also results in a 20% inc...of view and a 14% increase in depth of field. A si...
With the touch of a button, the Marco Encore Automatic Chair quickly reclines from an upright position to a fully horizontal, flat-table mode-or anywhere in between.
Both the Marco Keratometer I and Keratometer II are one position instruments for objectively measuring corneal curvature. The keratometer II has the added feature of internal readings for the presbyo
Medicine Products: